GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,058 | 9,768 | 23,862 | 27,492 | 25,949 |
| Depreciation Amortization | 815 | 2,898 | 1,626 | 972 | 807 |
| Accounts payable and accrued liabilities | N/A | 2,813 | N/A | N/A | N/A |
| Other Working Capital | 523 | 2,813 | 2,403 | 1,508 | 976 |
| Other Operating Activity | 3,070 | -20,222 | -29,686 | -31,204 | -27,899 |
| Operating Cash Flow | $-650 | $-1,930 | $-1,795 | $-1,232 | $-167 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 866 | 1,902 | 1,902 | 1,540 | 150 |
| Financing Cash Flow | $866 | $1,902 | $1,902 | $1,540 | $150 |
| Beginning Cash Position | 19 | 47 | 47 | 47 | 47 |
| End Cash Position | 235 | 19 | 154 | 355 | 30 |
| Net Cash Flow | $216 | $-28 | $107 | $308 | $-17 |
| Free Cash Flow | |||||
| Operating Cash Flow | -650 | -1,930 | -1,795 | -1,232 | -167 |
| Free Cash Flow | -650 | -1,930 | -1,795 | -1,232 | -167 |